StockTipsArenaBeta

BUY Max Healthcare Institute Limited — Kavita Jain, Arihant Capital Markets

BUYMax Healthcare Institute Limited

byKavita Jain, Arihant Capital MarketsHorizon: Swing (≤2wk)11 Sept 2026via CNBC Awaaz.

Entry₹1,048Inferred
Target₹1,080
Total upside +3.05%
Stop loss₹1,025-2.19% risk
CMP₹1,030Just now
Active-1.72%+4.85%upside left 13d left
Follow Kavita Jain for new calls(47% target hit, 55 closed calls)Get alertsWatch MAXHEALTH for new buy/sell callsGet alertsSee 1 other Swing call on MAXHEALTHSee 64 other Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 15 Sept, 4:04 pm IST
6 supporting1 neutral0 opposing
Supports the BUY call (6)

MACD above its signal line — bullish momentum

Technicals · macd·15 Sept · today

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·10 Sept · 5d ago

Max Healthcare Institute Ltd has received communication confirming the allotment of 50,21,212 equity shares in Kalinga Hospital Ltd. This infusion of ~87.87 Crore increases Max Healthcare's shareholdi

BSE · Company Update·7 Sept · 1w ago

(opens in new tab)

Max Healthcare Institute Ltd is infusing funds into Kalinga Hospital Ltd, indicating an expansion or investment in its healthcare facilities.

BSE · Company Update·3 Sept · 2w ago

(opens in new tab)

Union Home Minister Amit Shah inaugurated a new 400-bed tower at Max Smart Super Speciality Hospital in Saket. This expansion is expected to enhance healthcare services.

BSE · Company Update·3 Sept · 2w ago

(opens in new tab)
Neutral / worth noting (1)

Max Healthcare Institute Limited has filed an update regarding petitions filed by BRS Capital against Kalinga Hospital Ltd. The NCLT heard the matter on Sep 8, 2026, and directed respondents to file a

NSE · Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company·11 Sept · 4d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.